| Product Code: ETC5242331 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Belgium`s aminoglycosides import market in 2024 continued to be dominated by key suppliers such as the USA, China, Singapore, Netherlands, and Metropolitan France. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a significant decline with a negative Compound Annual Growth Rate (CAGR) of -11.37% from 2020 to 2024. The growth rate from 2023 to 2024 also saw a steep decline of -46.52%, reflecting challenges in the market dynamics and potential shifts in sourcing strategies.

By 2027, the Aminoglycosides market in Belgium is anticipated to reach a growth rate of 1.73%, as part of an increasingly competitive Europe region, where Germany remains at the forefront, supported by United Kingdom, France, Italy and Russia, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Aminoglycosides Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Aminoglycosides Market - Industry Life Cycle |
3.4 Belgium Aminoglycosides Market - Porter's Five Forces |
3.5 Belgium Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Belgium Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Belgium Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Belgium Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Belgium |
4.2.2 Rising demand for aminoglycosides due to their effectiveness in treating certain infections |
4.2.3 Growing investments in healthcare infrastructure and facilities in Belgium |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approvals for aminoglycoside drugs |
4.3.2 Potential side effects and toxicity associated with aminoglycosides |
4.3.3 Competition from alternative antibiotics and antimicrobial agents |
5 Belgium Aminoglycosides Market Trends |
6 Belgium Aminoglycosides Market Segmentations |
6.1 Belgium Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Belgium Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.3 Belgium Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.4 Belgium Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.5 Belgium Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.6 Belgium Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.7 Belgium Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Belgium Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Belgium Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Belgium Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Belgium Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Belgium Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Belgium Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Belgium Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Belgium Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Belgium Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Belgium Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Belgium Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Belgium Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Belgium Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Belgium Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Belgium Aminoglycosides Market Import-Export Trade Statistics |
7.1 Belgium Aminoglycosides Market Export to Major Countries |
7.2 Belgium Aminoglycosides Market Imports from Major Countries |
8 Belgium Aminoglycosides Market Key Performance Indicators |
8.1 Rate of adoption of aminoglycosides in Belgian hospitals and healthcare facilities |
8.2 Number of clinical studies and research projects focusing on aminoglycosides in Belgium |
8.3 Percentage of healthcare professionals trained on the proper use and administration of aminoglycoside medications |
9 Belgium Aminoglycosides Market - Opportunity Assessment |
9.1 Belgium Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Belgium Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Belgium Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Belgium Aminoglycosides Market - Competitive Landscape |
10.1 Belgium Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Belgium Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here